DIAM is designed to act as a shock absorber and function as a minimally invasive alternative to traditional spinal fusion.
Medtronic, a Minneapolis-based medical technology company, is sponsoring the clinical trial.
More Articles on Spine:
Mazor Robotics’ Renaissance System Comes to Houston Westside Surgical Hospital
Outpatient Cervical and Lumbar Spinal Fusion Research: Q&A With Dr. Jeffrey Carlson
Spine Team Texas First in Dallas Area to Implant Precision Spectra
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
